nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Glucose tolerance decreased—Niacin—atherosclerosis	0.0443	0.0684	CcSEcCtD
Fludrocortisone—Trauma—Pravastatin—atherosclerosis	0.0184	0.0284	CcSEcCtD
Fludrocortisone—Myopathy—Rosuvastatin—atherosclerosis	0.0174	0.0269	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—atherosclerosis	0.017	0.0576	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.0154	0.0522	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.0154	0.0519	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Niacin—atherosclerosis	0.0149	0.0231	CcSEcCtD
Fludrocortisone—Myopathy—Lovastatin—atherosclerosis	0.0148	0.0228	CcSEcCtD
Fludrocortisone—Myopathy—Ezetimibe—atherosclerosis	0.0145	0.0223	CcSEcCtD
Fludrocortisone—Myopathy—Simvastatin—atherosclerosis	0.0138	0.0213	CcSEcCtD
Fludrocortisone—Peptic ulcer—Niacin—atherosclerosis	0.0133	0.0205	CcSEcCtD
Fludrocortisone—AR—penis—atherosclerosis	0.0128	0.356	CbGeAlD
Fludrocortisone—Myopathy—Niacin—atherosclerosis	0.0127	0.0196	CcSEcCtD
Fludrocortisone—Myopathy—Pravastatin—atherosclerosis	0.0125	0.0193	CcSEcCtD
Fludrocortisone—Glaucoma—Niacin—atherosclerosis	0.0118	0.0182	CcSEcCtD
Fludrocortisone—Cataract—Lovastatin—atherosclerosis	0.0109	0.0168	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGT—atherosclerosis	0.0108	0.0365	CbGpPWpGaD
Fludrocortisone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.0102	0.0157	CcSEcCtD
Fludrocortisone—Cataract—Simvastatin—atherosclerosis	0.0102	0.0157	CcSEcCtD
Fludrocortisone—Injury—Rosuvastatin—atherosclerosis	0.00964	0.0149	CcSEcCtD
Fludrocortisone—Cataract—Pravastatin—atherosclerosis	0.00919	0.0142	CcSEcCtD
Fludrocortisone—Fluid retention—Niacin—atherosclerosis	0.00844	0.013	CcSEcCtD
Fludrocortisone—Vascular purpura—Lovastatin—atherosclerosis	0.0084	0.013	CcSEcCtD
Fludrocortisone—Injury—Lovastatin—atherosclerosis	0.00817	0.0126	CcSEcCtD
Fludrocortisone—Oesophagitis—Niacin—atherosclerosis	0.00812	0.0125	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Niacin—atherosclerosis	0.00808	0.0125	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Simvastatin—atherosclerosis	0.00808	0.0125	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.00793	0.0268	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Simvastatin—atherosclerosis	0.00785	0.0121	CcSEcCtD
Fludrocortisone—Muscular weakness—Rosuvastatin—atherosclerosis	0.00782	0.0121	CcSEcCtD
Fludrocortisone—Purpura—Lovastatin—atherosclerosis	0.00779	0.012	CcSEcCtD
Fludrocortisone—Pancreatitis—Rosuvastatin—atherosclerosis	0.00751	0.0116	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Niacin—atherosclerosis	0.00742	0.0115	CcSEcCtD
Fludrocortisone—Purpura—Simvastatin—atherosclerosis	0.00729	0.0113	CcSEcCtD
Fludrocortisone—Vascular purpura—Pravastatin—atherosclerosis	0.0071	0.011	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.00692	0.0234	CbGpPWpGaD
Fludrocortisone—Injury—Pravastatin—atherosclerosis	0.00691	0.0107	CcSEcCtD
Fludrocortisone—Purpura—Pravastatin—atherosclerosis	0.00659	0.0102	CcSEcCtD
Fludrocortisone—Muscular weakness—Ezetimibe—atherosclerosis	0.0065	0.01	CcSEcCtD
Fludrocortisone—Pancreatitis—Lovastatin—atherosclerosis	0.00636	0.00983	CcSEcCtD
Fludrocortisone—Affect lability—Pravastatin—atherosclerosis	0.00625	0.00966	CcSEcCtD
Fludrocortisone—Pancreatitis—Ezetimibe—atherosclerosis	0.00624	0.00964	CcSEcCtD
Fludrocortisone—Betamethasone—PLA2G1B—atherosclerosis	0.00621	0.304	CrCbGaD
Fludrocortisone—Muscular weakness—Simvastatin—atherosclerosis	0.0062	0.00957	CcSEcCtD
Fludrocortisone—Mood swings—Pravastatin—atherosclerosis	0.00602	0.00929	CcSEcCtD
Fludrocortisone—Pancreatitis—Simvastatin—atherosclerosis	0.00595	0.00919	CcSEcCtD
Fludrocortisone—Muscular weakness—Niacin—atherosclerosis	0.00569	0.00879	CcSEcCtD
Fludrocortisone—Abdominal distension—Niacin—atherosclerosis	0.00561	0.00867	CcSEcCtD
Fludrocortisone—Muscular weakness—Pravastatin—atherosclerosis	0.0056	0.00865	CcSEcCtD
Fludrocortisone—Abdominal distension—Pravastatin—atherosclerosis	0.00553	0.00853	CcSEcCtD
Fludrocortisone—Pancreatitis—Pravastatin—atherosclerosis	0.00538	0.00831	CcSEcCtD
Fludrocortisone—Sweating increased—Pravastatin—atherosclerosis	0.00535	0.00826	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.00524	0.0177	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00488	0.0165	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00463	0.0156	CbGpPWpGaD
Fludrocortisone—Myalgia—Rosuvastatin—atherosclerosis	0.00454	0.00702	CcSEcCtD
Fludrocortisone—Haemoglobin—Niacin—atherosclerosis	0.00449	0.00693	CcSEcCtD
Fludrocortisone—Haemorrhage—Niacin—atherosclerosis	0.00446	0.00689	CcSEcCtD
Fludrocortisone—Erythema—Ezetimibe—atherosclerosis	0.00444	0.00685	CcSEcCtD
Fludrocortisone—Infection—Rosuvastatin—atherosclerosis	0.00433	0.00668	CcSEcCtD
Fludrocortisone—Erythema—Simvastatin—atherosclerosis	0.00423	0.00653	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.0042	0.0142	CbGpPWpGaD
Fludrocortisone—Vertigo—Lovastatin—atherosclerosis	0.00406	0.00628	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR2—atherosclerosis	0.00406	0.0137	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00397	0.00613	CcSEcCtD
Fludrocortisone—Insomnia—Rosuvastatin—atherosclerosis	0.00394	0.00608	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.00393	0.0133	CbGpPWpGaD
Fludrocortisone—Erythema—Niacin—atherosclerosis	0.00388	0.006	CcSEcCtD
Fludrocortisone—Myalgia—Lovastatin—atherosclerosis	0.00385	0.00595	CcSEcCtD
Fludrocortisone—Hypertension—Ezetimibe—atherosclerosis	0.00383	0.00592	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00383	0.0129	CbGpPWpGaD
Fludrocortisone—Vertigo—Simvastatin—atherosclerosis	0.0038	0.00587	CcSEcCtD
Fludrocortisone—Myalgia—Ezetimibe—atherosclerosis	0.00378	0.00583	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00373	0.0126	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Lovastatin—atherosclerosis	0.00369	0.0057	CcSEcCtD
Fludrocortisone—Infection—Lovastatin—atherosclerosis	0.00367	0.00566	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.00367	0.0124	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00362	0.00559	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—PARP1—atherosclerosis	0.00362	0.0122	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PLA2G1B—atherosclerosis	0.00361	0.177	CrCbGaD
Fludrocortisone—Myalgia—Simvastatin—atherosclerosis	0.0036	0.00556	CcSEcCtD
Fludrocortisone—Infection—Ezetimibe—atherosclerosis	0.0036	0.00556	CcSEcCtD
Fludrocortisone—Vertigo—Niacin—atherosclerosis	0.00349	0.00539	CcSEcCtD
Fludrocortisone—Urticaria—Rosuvastatin—atherosclerosis	0.00346	0.00534	CcSEcCtD
Fludrocortisone—Oedema—Simvastatin—atherosclerosis	0.00345	0.00533	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Simvastatin—atherosclerosis	0.00345	0.00533	CcSEcCtD
Fludrocortisone—Vertigo—Pravastatin—atherosclerosis	0.00344	0.00531	CcSEcCtD
Fludrocortisone—Infection—Simvastatin—atherosclerosis	0.00343	0.0053	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00336	0.00519	CcSEcCtD
Fludrocortisone—Insomnia—Lovastatin—atherosclerosis	0.00334	0.00516	CcSEcCtD
Fludrocortisone—Myalgia—Niacin—atherosclerosis	0.00331	0.00511	CcSEcCtD
Fludrocortisone—Hypertension—Pravastatin—atherosclerosis	0.0033	0.0051	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0033	0.00509	CcSEcCtD
Fludrocortisone—Insomnia—Ezetimibe—atherosclerosis	0.00327	0.00506	CcSEcCtD
Fludrocortisone—Myalgia—Pravastatin—atherosclerosis	0.00326	0.00503	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.00321	0.0108	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00321	0.00496	CcSEcCtD
Fludrocortisone—NR3C2—connective tissue—atherosclerosis	0.00321	0.089	CbGeAlD
Fludrocortisone—Oedema—Niacin—atherosclerosis	0.00317	0.0049	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Niacin—atherosclerosis	0.00317	0.0049	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00315	0.00486	CcSEcCtD
Fludrocortisone—Asthenia—Rosuvastatin—atherosclerosis	0.00313	0.00483	CcSEcCtD
Fludrocortisone—Insomnia—Simvastatin—atherosclerosis	0.00312	0.00482	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00312	0.00482	CcSEcCtD
Fludrocortisone—Oedema—Pravastatin—atherosclerosis	0.00312	0.00482	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—SOD1—atherosclerosis	0.00311	0.0105	CbGpPWpGaD
Fludrocortisone—Infection—Pravastatin—atherosclerosis	0.0031	0.00479	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.00308	0.0104	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Niacin—atherosclerosis	0.00306	0.00473	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.00303	0.0102	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Pravastatin—atherosclerosis	0.00302	0.00466	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RETN—atherosclerosis	0.00301	0.0102	CbGpPWpGaD
Fludrocortisone—Urticaria—Lovastatin—atherosclerosis	0.00293	0.00453	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00289	0.00446	CcSEcCtD
Fludrocortisone—Urticaria—Ezetimibe—atherosclerosis	0.00288	0.00444	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—APOB—atherosclerosis	0.00287	0.00969	CbGpPWpGaD
Fludrocortisone—Insomnia—Niacin—atherosclerosis	0.00287	0.00443	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.00287	0.00968	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00284	0.00439	CcSEcCtD
Fludrocortisone—Insomnia—Pravastatin—atherosclerosis	0.00282	0.00436	CcSEcCtD
Fludrocortisone—NR3C2—cardiovascular system—atherosclerosis	0.00279	0.0774	CbGeAlD
Fludrocortisone—Urticaria—Simvastatin—atherosclerosis	0.00274	0.00424	CcSEcCtD
Fludrocortisone—Headache—Rosuvastatin—atherosclerosis	0.00273	0.00421	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARA—atherosclerosis	0.00272	0.00919	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Lovastatin—atherosclerosis	0.00272	0.0042	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—F7—atherosclerosis	0.00272	0.00917	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Ezetimibe—atherosclerosis	0.00267	0.00412	CcSEcCtD
Fludrocortisone—Asthenia—Lovastatin—atherosclerosis	0.00265	0.00409	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00264	0.00892	CbGpPWpGaD
Fludrocortisone—Asthenia—Ezetimibe—atherosclerosis	0.0026	0.00401	CcSEcCtD
Fludrocortisone—Hypersensitivity—Simvastatin—atherosclerosis	0.00254	0.00393	CcSEcCtD
Fludrocortisone—Urticaria—Niacin—atherosclerosis	0.00252	0.00389	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00251	0.00847	CbGpPWpGaD
Fludrocortisone—Urticaria—Pravastatin—atherosclerosis	0.00248	0.00383	CcSEcCtD
Fludrocortisone—Asthenia—Simvastatin—atherosclerosis	0.00248	0.00383	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR1—atherosclerosis	0.00246	0.00832	CbGpPWpGaD
Fludrocortisone—NR3C2—adipose tissue—atherosclerosis	0.00246	0.0683	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.00244	0.00823	CbGpPWpGaD
Fludrocortisone—AR—connective tissue—atherosclerosis	0.00237	0.0659	CbGeAlD
Fludrocortisone—Hypersensitivity—Niacin—atherosclerosis	0.00234	0.00361	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.00232	0.00784	CbGpPWpGaD
Fludrocortisone—Headache—Lovastatin—atherosclerosis	0.00231	0.00357	CcSEcCtD
Fludrocortisone—Hypersensitivity—Pravastatin—atherosclerosis	0.0023	0.00355	CcSEcCtD
Fludrocortisone—Asthenia—Niacin—atherosclerosis	0.00227	0.00351	CcSEcCtD
Fludrocortisone—Headache—Ezetimibe—atherosclerosis	0.00227	0.0035	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—atherosclerosis	0.00225	0.00759	CbGpPWpGaD
Fludrocortisone—Asthenia—Pravastatin—atherosclerosis	0.00224	0.00346	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—atherosclerosis	0.00219	0.0074	CbGpPWpGaD
Fludrocortisone—Headache—Simvastatin—atherosclerosis	0.00216	0.00334	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00215	0.00726	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.00211	0.00712	CbGpPWpGaD
Fludrocortisone—AR—cardiovascular system—atherosclerosis	0.00207	0.0573	CbGeAlD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.00206	0.00697	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—atherosclerosis	0.00204	0.1	CrCbGaD
Fludrocortisone—Headache—Niacin—atherosclerosis	0.00199	0.00307	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—INS—atherosclerosis	0.00196	0.00662	CbGpPWpGaD
Fludrocortisone—Headache—Pravastatin—atherosclerosis	0.00196	0.00302	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00195	0.00658	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00193	0.00652	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.00193	0.00651	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.0019	0.00642	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00187	0.00631	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00187	0.00631	CbGpPWpGaD
Fludrocortisone—AR—adipose tissue—atherosclerosis	0.00182	0.0506	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00178	0.006	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00177	0.00599	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.00175	0.0859	CrCbGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.00174	0.00588	CbGpPWpGaD
Fludrocortisone—NR3C2—liver—atherosclerosis	0.00173	0.0479	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.00172	0.00581	CbGpPWpGaD
Fludrocortisone—NR3C1—connective tissue—atherosclerosis	0.00172	0.0477	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00171	0.00578	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.00171	0.00576	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SIRT1—atherosclerosis	0.00166	0.00559	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00165	0.00556	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.00164	0.00555	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00163	0.00551	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NOS2—atherosclerosis	0.00161	0.079	CrCbGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.00157	0.0053	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK3—atherosclerosis	0.00155	0.00524	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00153	0.00518	CbGpPWpGaD
Fludrocortisone—NR3C1—cardiovascular system—atherosclerosis	0.0015	0.0415	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.00149	0.00502	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00148	0.00499	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.00148	0.00499	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00147	0.00498	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00146	0.00494	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.00146	0.00493	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.00146	0.00493	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.00144	0.00486	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.0014	0.00474	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.00136	0.00461	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00135	0.00455	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00134	0.00454	CbGpPWpGaD
Fludrocortisone—NR3C1—adipose tissue—atherosclerosis	0.00132	0.0366	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00131	0.00443	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.0013	0.00439	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CAV1—atherosclerosis	0.00129	0.00437	CbGpPWpGaD
Fludrocortisone—AR—liver—atherosclerosis	0.00128	0.0355	CbGeAlD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PARP1—atherosclerosis	0.00126	0.00426	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.00124	0.00419	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00123	0.00414	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—atherosclerosis	0.0012	0.00404	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00118	0.00398	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—atherosclerosis	0.00116	0.00393	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00116	0.0039	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00115	0.00387	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.00114	0.00386	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—atherosclerosis	0.00114	0.00384	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00113	0.00382	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00112	0.00377	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00111	0.00373	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.00109	0.00369	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.00108	0.00366	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—atherosclerosis	0.00105	0.00353	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00102	0.00345	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00101	0.00342	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—atherosclerosis	0.00101	0.0496	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.00101	0.00341	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000996	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000994	0.00336	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00098	0.00331	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—atherosclerosis	0.000971	0.0476	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atherosclerosis	0.000945	0.00319	CbGpPWpGaD
Fludrocortisone—NR3C1—liver—atherosclerosis	0.000926	0.0257	CbGeAlD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000899	0.00304	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000884	0.00299	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000877	0.00296	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000873	0.00295	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000858	0.0029	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—atherosclerosis	0.000855	0.00289	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000839	0.00283	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000817	0.00276	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000801	0.00271	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARA—atherosclerosis	0.0008	0.0027	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000798	0.0027	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—atherosclerosis	0.000796	0.039	CrCbGaD
Fludrocortisone—Prednisone—ALB—atherosclerosis	0.000785	0.0385	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000771	0.00261	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000769	0.0026	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000756	0.00255	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000747	0.00252	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—atherosclerosis	0.000735	0.036	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000732	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—atherosclerosis	0.000725	0.00245	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000722	0.00244	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000703	0.00238	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—atherosclerosis	0.000698	0.00236	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HSPA1B—atherosclerosis	0.000682	0.0023	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000677	0.00229	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—atherosclerosis	0.000661	0.00223	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000638	0.00215	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000629	0.00213	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—atherosclerosis	0.000625	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000619	0.00209	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000609	0.00206	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—atherosclerosis	0.000609	0.00206	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PARP1—atherosclerosis	0.000608	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000605	0.00204	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.0006	0.00203	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000596	0.00201	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000595	0.00201	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000586	0.00198	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PARP1—atherosclerosis	0.000586	0.00198	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—atherosclerosis	0.000575	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000574	0.00194	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—atherosclerosis	0.000555	0.00187	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000554	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.00054	0.00182	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000532	0.0018	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000509	0.00172	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000496	0.00167	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000486	0.00164	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000485	0.00164	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—atherosclerosis	0.000463	0.00157	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—atherosclerosis	0.000463	0.0227	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.000462	0.00156	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.00045	0.00152	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—atherosclerosis	0.00045	0.00152	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000448	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000444	0.0015	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—atherosclerosis	0.000426	0.0209	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000422	0.00142	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000421	0.00142	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00042	0.00142	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000415	0.0014	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000403	0.00136	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000395	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000391	0.00132	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000386	0.0013	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARA—atherosclerosis	0.000385	0.0013	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000383	0.00129	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000376	0.00127	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARA—atherosclerosis	0.000371	0.00125	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000368	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000364	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000363	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000362	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000351	0.00119	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—atherosclerosis	0.000349	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000341	0.00115	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000339	0.00114	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—atherosclerosis	0.000336	0.00114	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000328	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—atherosclerosis	0.000318	0.00108	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPA1B—atherosclerosis	0.000316	0.00107	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000311	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—atherosclerosis	0.000307	0.00104	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.000295	0.000995	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000293	0.000988	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—atherosclerosis	0.000287	0.000969	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PARP1—atherosclerosis	0.000282	0.000952	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000282	0.000951	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000276	0.000934	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000273	0.000923	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—atherosclerosis	0.000267	0.000902	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000255	0.000862	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000244	0.000825	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.00024	0.000811	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000236	0.000798	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000233	0.000786	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SIRT1—atherosclerosis	0.000215	0.000726	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000214	0.000722	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.00021	0.000708	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000203	0.000684	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—atherosclerosis	0.000187	0.00063	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARA—atherosclerosis	0.000179	0.000604	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.000163	0.000551	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—atherosclerosis	0.000162	0.000547	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—atherosclerosis	0.000148	0.000499	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARA—atherosclerosis	0.000136	0.000458	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—atherosclerosis	0.000133	0.00045	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—atherosclerosis	0.000126	0.000425	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—atherosclerosis	0.000123	0.000415	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—atherosclerosis	0.000112	0.000379	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	0.000101	0.000341	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—atherosclerosis	8.66e-05	0.000292	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—atherosclerosis	6.57e-05	0.000222	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—atherosclerosis	5.84e-05	0.000197	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—atherosclerosis	4.43e-05	0.00015	CbGpPWpGaD
